CNTB - long - catalyst play
Zaktualizowano
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
This is not a financial advice!
Upcoming catalyst on 31st. of March
I would wait for a pullback to the 1. 20 level for a better entry
Keep an eye on 1.77 level - needs to get broken for a further upmove.
SL under 1.10
TP approx. 2.8
Most info on the chart.
Trade carefully!
This is not a financial advice!
Upcoming catalyst on 31st. of March
I would wait for a pullback to the 1. 20 level for a better entry
Keep an eye on 1.77 level - needs to get broken for a further upmove.
SL under 1.10
TP approx. 2.8
Most info on the chart.
Trade carefully!
Uwaga
Entry zone is hereTransakcja zakończona: osiągnięto poziom stop
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.